LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 115 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,601 | -44.5% | 28,475 | -33.7% | 0.00% | – |
| Q2 2023 | $60,528 | -27.1% | 42,928 | -20.0% | 0.00% | – |
| Q1 2022 | $83,000 | -50.0% | 53,656 | -20.8% | 0.00% | – |
| Q4 2021 | $166,000 | +1.2% | 67,780 | +4.0% | 0.00% | – |
| Q3 2021 | $164,000 | -65.6% | 65,203 | -61.0% | 0.00% | -100.0% |
| Q2 2021 | $477,000 | +243.2% | 167,396 | -0.6% | 0.00% | – |
| Q1 2020 | $139,000 | -6.1% | 168,433 | +1.2% | 0.00% | – |
| Q4 2019 | $148,000 | -9.2% | 166,508 | 0.0% | 0.00% | – |
| Q3 2019 | $163,000 | – | 166,508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,005,379 | $28,160,000 | 3.29% |
| Defender Capital, LLC. | 4,416,590 | $3,657,000 | 2.67% |
| Prescott General Partners LLC | 1,851,851 | $1,534,000 | 0.13% |
| Laidlaw Wealth Management LLC | 107,379 | $89,000 | 0.06% |
| Northeast Financial Consultants Inc | 523,756 | $434,000 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $37,000 | 0.04% |
| DAFNA Capital Management LLC | 95,000 | $79,000 | 0.03% |
| Summit X, LLC | 30,700 | $25,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 529,039 | $438,000 | 0.01% |
| Keudell/Morrison Wealth Management | 10,105 | $8,000 | 0.01% |